{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:45:41Z","timestamp":1790419541554,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007688","name":"American University of Beirut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.trsl.2021.03.010","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T02:52:24Z","timestamp":1616208744000},"page":"85-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Pharmacological regulation of cytochrome P450 metabolites of arachidonic acid attenuates cardiac injury in diabetic rats"],"prefix":"10.1016","volume":"235","author":[{"given":"Lynn M.","family":"Alaeddine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Harb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maysaa","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batoul","family":"Dia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahed","family":"Mogharbil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim S.","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Noureldein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"El Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzi","family":"Sabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assaad A.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2021.03.010_bib0001","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIR.0000000000000034","article-title":"Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association","volume":"130","author":"De Ferranti","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.trsl.2021.03.010_bib0002","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.2337\/dc14-0096","article-title":"Mortality trends among people with type 1 and type 2 diabetes in Australia: 1997\u20132010","volume":"37","author":"Harding","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2021.03.010_bib0003","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.jacc.2013.03.023","article-title":"Trends in predicted 10-year risk of coronary heart disease and cardiovascular disease among US adults from 1999 to 2010","volume":"61","author":"Ford","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0004","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","article-title":"Diabetic cardiomyopathy: pathophysiology and clinical features","volume":"18","author":"Miki","year":"2013","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.trsl.2021.03.010_bib0005","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease: the Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2021.03.010_bib0006","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2021.03.010_bib0007","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.2337\/diacare.26.10.2791","article-title":"Diabetes and idiopathic cardiomyopathy: a nationwide case-control study","volume":"26","author":"Bertoni","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2021.03.010_bib0008","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2021.03.010_bib0009","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/JOE-16-0679","article-title":"Insulin receptor substrate signaling controls cardiac energy metabolism and heart failure","volume":"233","author":"Guo","year":"2017","journal-title":"The Journal of Endocrinology"},{"key":"10.1016\/j.trsl.2021.03.010_bib0010","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/cvr\/cvx018","article-title":"Metabolic remodelling in diabetic cardiomyopathy","volume":"113","author":"Chong","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trsl.2021.03.010_bib0011","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1900\/RDS.2006.3.108","article-title":"Causes and characteristics of diabetic cardiomyopathy","volume":"3","author":"Wang","year":"2006","journal-title":"The Review of Diabetic Studies"},{"key":"10.1016\/j.trsl.2021.03.010_bib0012","doi-asserted-by":"crossref","first-page":"489","DOI":"10.33549\/physiolres.932467","article-title":"Morphology and contractility of cardiac myocytes in early stages of streptozotocin-induced diabetes mellitus in rats","volume":"62","author":"Cagalinec","year":"2013","journal-title":"Physiol Res"},{"key":"10.1016\/j.trsl.2021.03.010_bib0013","doi-asserted-by":"crossref","first-page":"H3065","DOI":"10.1152\/ajpheart.01224.2006","article-title":"Activity of the \u03b2-myosin heavy chain antisense promoter responds to diabetes and hypothyroidism","volume":"292","author":"Giger","year":"2007","journal-title":"Am J Physiol-Heart Circul Physiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0014","doi-asserted-by":"crossref","first-page":"C597","DOI":"10.1152\/ajpcell.00331.2011","article-title":"Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes","volume":"302","author":"Maalouf","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0015","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","article-title":"An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy","volume":"168","author":"Palomer","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0016","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12933-017-0506-x","article-title":"Diagnostic approaches for diabetic cardiomyopathy","volume":"16","author":"Lorenzo-Almoros","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0017","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","article-title":"An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy","volume":"168","author":"Palomer","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0018","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tips.2018.02.010","article-title":"Emerging actors in diabetic cardiomyopathy: heartbreaker biomarkers or therapeutic targets?","volume":"39","author":"Palomer","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.trsl.2021.03.010_bib0019","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/1755-5922.12079","article-title":"Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits","volume":"32","author":"Liu","year":"2014","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.trsl.2021.03.010_bib0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1385\/CBB:43:2:289","article-title":"The role of oxidative stress in diabetic complications","volume":"43","author":"Niedowicz","year":"2005","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.trsl.2021.03.010_bib0021","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/03602538909103562","article-title":"Physiological and pathophysiological alterations in rat hepatic cytochrome P450","volume":"20","author":"Schenkman","year":"1989","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.trsl.2021.03.010_bib0022","series-title":"The Idea of Higher Education","author":"Barnett","year":"1990"},{"key":"10.1016\/j.trsl.2021.03.010_bib0023","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1172\/JCI114734","article-title":"Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle","volume":"86","author":"Litwin","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2021.03.010_bib0024","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00424-010-0804-6","article-title":"Epoxyeicosatrienoic acids and endothelium-dependent responses","volume":"459","author":"Campbell","year":"2010","journal-title":"Pfl\u00fcgers Archiv-Eur J Physiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/bs.apha.2016.04.003","article-title":"Epoxyeicosatrienoic acids and 20-hydroxyeicosatetraenoic acid on endothelial and vascular function","volume":"77","author":"Imig","year":"2016","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0026","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.trsl.2021.03.010_bib0027","doi-asserted-by":"crossref","first-page":"F95","DOI":"10.1152\/ajprenal.00132.2002","article-title":"Distribution of cytochrome P-450 4A and 4F isoforms along the nephron in mice","volume":"284","author":"Stec","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0028","first-page":"74","article-title":"Recent developments on the vascular effects of 20-hydroxyeicosatetraenoic acid","volume":"26","author":"Garcia","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.trsl.2021.03.010_bib0029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prostaglandins.2015.03.002","article-title":"Vascular actions of 20-HETE","volume":"120","author":"Hoopes","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.trsl.2021.03.010_bib0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/FJC.0b013e318273b007","article-title":"Epoxyeicosatrienoic acid pathway in human health and diseases","volume":"61","author":"Bellien","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0031","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharmthera.2018.07.004","article-title":"20-HETE in the regulation of vascular and cardiac function","volume":"192","author":"Rocic","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.trsl.2021.03.010_bib0032","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.fct.2009.02.007","article-title":"Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats","volume":"47","author":"Yousef","year":"2009","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0033","doi-asserted-by":"crossref","first-page":"H853","DOI":"10.1152\/ajpheart.00154.2012","article-title":"Pharmacological inhibition of soluble epoxide hydrolase provides cardioprotection in hyperglycemic rats","volume":"303","author":"Guglielmino","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198203","article-title":"Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps","volume":"13","author":"Danish","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2021.03.010_bib0035","doi-asserted-by":"crossref","first-page":"H537","DOI":"10.1152\/ajpheart.00071.2006","article-title":"Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury","volume":"291","author":"Nithipatikom","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0036","first-page":"1245","article-title":"Cytochrome P450 omega-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal KATP channel","volume":"37","author":"Gross","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0037","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2008.08.008","article-title":"Cytochrome P450 omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1\/2 signaling in rat myocardial ischemia-reperfusion","volume":"596","author":"Lv","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0038","doi-asserted-by":"crossref","first-page":"F71","DOI":"10.1152\/ajprenal.00458.2015","article-title":"20-HETE and CYP4A2 omega-hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats","volume":"311","author":"Dalmasso","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0039","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.jacc.2016.01.076","article-title":"Constrictive pericarditis versus restrictive cardiomyopathy?","volume":"67","author":"Garcia","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.prostaglandins.2012.12.001","article-title":"Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model","volume":"104-105","author":"Chen","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.trsl.2021.03.010_bib0041","doi-asserted-by":"crossref","first-page":"H528","DOI":"10.1152\/ajpheart.00561.2016","article-title":"Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction","volume":"312","author":"Joseph","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0042","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1242\/dmm.001941","article-title":"Rodent models of diabetic cardiomyopathy","volume":"2","author":"Bugger","year":"2009","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.trsl.2021.03.010_bib0043","doi-asserted-by":"crossref","first-page":"R1439","DOI":"10.1152\/ajpregu.00736.2007","article-title":"Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy","volume":"295","author":"Suarez","year":"2008","journal-title":"Am J Physiol Regulat Integr Comp Physiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0044","doi-asserted-by":"crossref","first-page":"27014","DOI":"10.1074\/jbc.M203458200","article-title":"Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice","volume":"277","author":"Nielsen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2021.03.010_bib0045","first-page":"2015","article-title":"Updating experimental models of diabetic cardiomyopathy","author":"Fuentes-Antras","year":"2015","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.trsl.2021.03.010_bib0046","first-page":"36","article-title":"Pathogenesis of type 1 diabetes mellitus and rodent experimental models","volume":"10","author":"Gvazava","year":"2018","journal-title":"Acta Naturae (\u0430\u043d\u0433\u043b\u043e\u044f\u0437\u044b\u0447\u043d\u0430\u044f \u0432\u0435\u0440\u0441\u0438\u044f)"},{"key":"10.1016\/j.trsl.2021.03.010_bib0047","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1128\/MCB.00217-13","article-title":"Sestrin 2 and AMPK connect hyperglycemia to Nox4-dependent endothelial nitric oxide synthase uncoupling and matrix protein expression","volume":"33","author":"Eid","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0048","first-page":"693","article-title":"Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy","volume":"27","author":"Eid","year":"2013","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.trsl.2021.03.010_bib0049","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/1753944708096379","article-title":"Cardiovascular disease in chronic kidney disease","volume":"2","author":"Saran","year":"2008","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.trsl.2021.03.010_bib0050","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1002\/jcp.22619","article-title":"TGF\u03b2 receptor activation enhances cardiac apoptosis via SMAD activation and concomitant NO release","volume":"226","author":"Heger","year":"2011","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0051","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0735-1097(99)00436-2","article-title":"Abnormal cardiac function in the streptozotocin-induced, non\u2013insulin-dependent diabetic rat: Noninvasive assessment with Doppler echocardiography and contribution of the nitric oxide pathway","volume":"34","author":"Joffe","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0052","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/1479164117710390","article-title":"Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat","volume":"14","author":"Tate","year":"2017","journal-title":"Diabet Vasc Dis Res"},{"key":"10.1016\/j.trsl.2021.03.010_bib0053","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00125-014-3164-5","article-title":"Prevalence of systolic and diastolic dysfunction in patients with type 1 diabetes without known heart disease: the Thousand & 1 Study","volume":"57","author":"Jensen","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.trsl.2021.03.010_bib0054","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/diabetes.50.6.1414","article-title":"IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II\u2013mediated oxidative stress","volume":"50","author":"Kajstura","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2021.03.010_bib0055","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2337\/db09-0259","article-title":"Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice","volume":"58","author":"Bugger","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2021.03.010_bib0056","doi-asserted-by":"crossref","first-page":"H2096","DOI":"10.1152\/ajpheart.00452.2009","article-title":"Type 1 diabetic cardiomyopathy in the Akita (Ins2 WT\/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function","volume":"297","author":"Basu","year":"2009","journal-title":"Am J Physiol-Heart Circul Physiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0057","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1210\/en.2006-0728","article-title":"Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes","volume":"147","author":"Aragno","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.trsl.2021.03.010_bib0058","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.trsl.2021.03.010_bib0059","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1210\/er.2003-0012","article-title":"Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications","volume":"25","author":"Fang","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.trsl.2021.03.010_bib0060","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S1071-9164(99)91337-4","article-title":"Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats","volume":"5","author":"Hoit","year":"1999","journal-title":"J Card Fail"},{"key":"10.1016\/j.trsl.2021.03.010_bib0061","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/01.RES.0000129254.25507.d6","article-title":"What mechanisms underlie diastolic dysfunction in heart failure?","volume":"94","author":"Kass","year":"2004","journal-title":"Circul Res"},{"key":"10.1016\/j.trsl.2021.03.010_bib0062","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1159\/000487690","article-title":"Type I diabetic akita mouse model is characterized by abnormal cardiac deformation during early stages of diabetic cardiomyopathy with speckle-tracking based strain imaging","volume":"45","author":"Zhou","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.trsl.2021.03.010_bib0063","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0891-5849(94)90152-X","article-title":"DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria","volume":"16","author":"Ha","year":"1994","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/j.trsl.2021.03.010_bib0064","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jep.2010.06.004","article-title":"Zhen-wu-tang, a blended traditional Chinese herbal medicine, ameliorates proteinuria and renal damage of streptozotocin-induced diabetic nephropathy in rats","volume":"131","author":"Cai","year":"2010","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0065","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/dmrr.472","article-title":"Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model","volume":"20","author":"Palm","year":"2004","journal-title":"Diabet\/Metab Res Rev"},{"key":"10.1016\/j.trsl.2021.03.010_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11684-019-0729-1","article-title":"Oxidative stress and diabetes: antioxidative strategies","volume":"14","author":"Zhang","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.trsl.2021.03.010_bib0067","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2337\/diabetes.55.03.06.db05-1039","article-title":"Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy","volume":"55","author":"Shen","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2021.03.010_bib0068","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/461967","article-title":"Alteration of energy substrates and ROS production in diabetic cardiomyopathy","volume":"2013","author":"Lorenzo","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.trsl.2021.03.010_bib0069","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pharmthera.2016.11.013","article-title":"Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential","volume":"172","author":"Faria","year":"2017","journal-title":"Pharmacol Therap"},{"key":"10.1016\/j.trsl.2021.03.010_bib0070","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.bbadis.2017.07.025","article-title":"The role of NADPH oxidases in diabetic cardiomyopathy","volume":"1864","author":"Hansen","year":"2018","journal-title":"Biochimica et Biophysica Acta (BBA)-Mol Basis Dis"},{"key":"10.1016\/j.trsl.2021.03.010_bib0071","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2337\/diabetes.51.4.1118","article-title":"Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol","volume":"51","author":"Desco","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2021.03.010_bib0072","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2337\/db06-0699","article-title":"Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes","volume":"56","author":"Thum","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2021.03.010_bib0073","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.trsl.2021.03.010_bib0074","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0006-2952(94)90235-6","article-title":"Contribution of hepatic cytochrome P450 systems to the generation of reactive oxygen species","volume":"48","author":"Bondy","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0075","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/746978","article-title":"NADPH oxidase versus mitochondria-derived ROS in glucose-induced apoptosis of pericytes in early diabetic retinopathy","volume":"2010","author":"Mustapha","year":"2010","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0076","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/BJ20061903","article-title":"NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation","volume":"406","author":"Serrander","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.trsl.2021.03.010_bib0077","doi-asserted-by":"crossref","first-page":"15565","DOI":"10.1073\/pnas.1002178107","article-title":"NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart","volume":"107","author":"Kuroda","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.trsl.2021.03.010_bib0078","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/03602532.2012.754460","article-title":"Role of cytochrome P450\u2013mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy","volume":"45","author":"Alsaad","year":"2013","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.trsl.2021.03.010_bib0079","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1073\/pnas.0503279102","article-title":"Soluble epoxide hydrolase is a therapeutic target for acute inflammation","volume":"102","author":"Schmelzer","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.trsl.2021.03.010_bib0080","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijcard.2011.12.062","article-title":"Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction","volume":"167","author":"Kompa","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0081","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FJC.0b013e3181506445","article-title":"The soluble epoxide hydrolase as a pharmaceutical target for hypertension","volume":"50","author":"Chiamvimonvat","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0082","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","article-title":"Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors","volume":"103","author":"Xu","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.trsl.2021.03.010_bib0083","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1476-5381.2009.00461.x","article-title":"3-Methylcholanthrene and benzo (a) pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats","volume":"158","author":"Aboutabl","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0084","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2008.08.008","article-title":"Cytochrome P450 \u03c9-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1\/2 signaling in rat myocardial ischemia-reperfusion","volume":"596","author":"Lv","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.107.089599","article-title":"Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension","volume":"50","author":"Singh","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2021.03.010_bib0086","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2174\/1389200211314060007","article-title":"20-Hydroxyeicosatetraenoic acid is a potential therapeutic target in cardiovascular diseases","volume":"14","author":"H Elshenawy","year":"2013","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.trsl.2021.03.010_bib0087","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1474-8673.2009.00429.x","article-title":"Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury","volume":"29","author":"Yousif","year":"2009","journal-title":"Autonom Autacoid Pharmacol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0088","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.prostaglandins.2006.05.017","article-title":"Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia\/reperfusion injury","volume":"82","author":"Seubert","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.trsl.2021.03.010_bib0089","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yjmcc.2014.05.016","article-title":"Epoxyeicosatrienoic acids and cardioprotection: the road to translation","volume":"74","author":"Oni-Orisan","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0090","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1210\/en.2012-2166","article-title":"Cardiac-specific overexpression of CYP2J2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic mice","volume":"154","author":"Ma","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.trsl.2021.03.010_bib0091","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1159\/000445663","article-title":"CYP2J2-derived EETs attenuated angiotensin II-induced adventitial remodeling via reduced inflammatory response","volume":"39","author":"Zhou","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.trsl.2021.03.010_bib0092","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1021\/pr4004739","article-title":"Proteomic analysis of hearts from Akita mice suggests that increases in soluble epoxide hydrolase and antioxidative programming are key changes in early stages of diabetic cardiomyopathy","volume":"12","author":"Dewey","year":"2013","journal-title":"J Proteome Res"},{"key":"10.1016\/j.trsl.2021.03.010_bib0093","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.redox.2015.09.009","article-title":"Reciprocal regulation of TGF-\u03b2 and reactive oxygen species: a perverse cycle for fibrosis","volume":"6","author":"Liu","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0094","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.RES.0000187457.24338.3D","article-title":"NAD (P) H oxidase 4 mediates transforming growth factor-\u03b21\u2013induced differentiation of cardiac fibroblasts into myofibroblasts","volume":"97","author":"Cucoranu","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2021.03.010_bib0095","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jnutbio.2014.03.010","article-title":"Increase in AMPK brought about by cocoa is renoprotective in experimental diabetes mellitus by reducing NOX4\/TGF\u03b2-1 signaling","volume":"25","author":"Papadimitriou","year":"2014","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.trsl.2021.03.010_bib0096","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1074\/jbc.M112.431973","article-title":"Mitochondrial reactive oxygen species regulate transforming growth factor-\u03b2 signaling","volume":"288","author":"Jain","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2021.03.010_bib0097","doi-asserted-by":"crossref","first-page":"F572","DOI":"10.1152\/ajprenal.00275.2017","article-title":"Molecular basis of the counteraction by calcium channel blockers of cyclosporine nephrotoxicity","volume":"315","author":"Hammoud","year":"2018","journal-title":"Am J Physiol-Renal Physiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0098","doi-asserted-by":"crossref","first-page":"F1276","DOI":"10.1152\/ajprenal.00396.2014","article-title":"Targeting NADPH oxidase with a novel dual Nox1\/Nox4 inhibitor attenuates renal pathology in type 1 diabetes","volume":"308","author":"Gorin","year":"2015","journal-title":"Am J Physiol-Renal Physiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0099","first-page":"1093","article-title":"Calcium\u2011sensing receptor promotes high glucose\u2011induced myocardial fibrosis via upregulation of the TGF\u2011\u03b21\/Smads pathway in cardiac fibroblasts","volume":"20","author":"Yuan","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.trsl.2021.03.010_bib0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.diabres.2017.08.018","article-title":"Transforming growth factor beta (TGF-\u03b2) mediates cardiac fibrosis and induces diabetic cardiomyopathy","volume":"133","author":"Yue","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.trsl.2021.03.010_bib0101","doi-asserted-by":"crossref","first-page":"F556","DOI":"10.1152\/ajprenal.90613.2008","article-title":"Glomerular 20-HETE, EETs, and TGF-\u03b21 in diabetic nephropathy","volume":"296","author":"Luo","year":"2009","journal-title":"Am J Physiol-Renal Physiol"},{"key":"10.1016\/j.trsl.2021.03.010_bib0102","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/db08-1536","article-title":"Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases","volume":"58","author":"Eid","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2021.03.010_bib0103","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1194\/jlr.M700155-JLR200","article-title":"20-HETE inhibits the proliferation of vascular smooth muscle cells via transforming growth factor-\u03b2","volume":"49","author":"Liang","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2021.03.010_bib0104","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.prostaglandins.2017.08.005","article-title":"20-HETE regulated PSMB5 expression via TGF-\u03b2\/Smad signaling pathway","volume":"134","author":"Lai","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.trsl.2021.03.010_bib0105","doi-asserted-by":"crossref","first-page":"F971","DOI":"10.1152\/ajprenal.00256.2014","article-title":"Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation","volume":"307","author":"Kim","year":"2014","journal-title":"Am J Physiol-Renal Physiol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524421000736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524421000736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:44:44Z","timestamp":1761828284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524421000736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":105,"alternative-id":["S1931524421000736"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2021.03.010","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological regulation of cytochrome P450 metabolites of arachidonic acid attenuates cardiac injury in diabetic rats","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2021.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}